ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and ...

ImmunoPrecise Antibodies Ltd., an AI-powered antibody company, has partnered with RIBOPRO, a technology provider specializing ...

This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.

About 60% of all cancer patients in the United States receive radiation therapy as part of their treatment. However, this ...

About 60 percent of all cancer patients in the United States receive radiation therapy as part of their treatment.